A Journey of Body and Mind
Véronique Dallaire, 33, was diagnosed with multiple sclerosis in June 2016, after having vision problems affecting her left eye. That same summer she…
Making lemonade with my MS
Guest blog post – Sarah Le Huray, MS Walk ambassador As soon as I saw my scans on the doctor’s computer screen, I…
Now is the time for cannabis research
By Pamela Valentine, President and Chief Executive Officer of the Multiple Sclerosis Society of Canada I’m concerned about cannabis. I’m not concerned for…
I See You Mama
Guest post written by Jamie Woytiuk My mom, Joanne, was diagnosed with primary-progressive multiple sclerosis (PPMS) in November 1998. I remember my dad…
ACTRIMS Forum 2019 and its focus on precision Medicine in MS
The theme of the #ACTRIMS Forum 2019 was “Precision Medicine Approaches for MS: Scientific Principles to Clinical Application.” Many talks and presentations were…
Behind the research: meet the CanProCo team
The Canadian Proactive Cohort Study for People Living with MS (CanProCo) is a revolutionary project in every sense of the word. Scope. Scale.…
Cutting Edge Developments: Treatment in development, technology-based clinical measures, and predicting progression in MS
Presenters at the cutting-edge developments in MS session at #ACTRIMS deliver the latest key findings on pivotal studies. At the session, we heard…
Emerging Concepts in MS: MRI measure as an indicator of potential conversion to SPMS, novel therapeutic targets of neuroinflammation, and roles of biological measures of aging in MS
Presenters at the emerging concepts in MS session at the ACTRIMS 2019 Forum deliver results on novel research areas in MS. At the…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.